In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]
Easy and fast I love this product
Published by: The Nutritional Medicine Institute Open Access: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence ( which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited
However, the modest efficacy demonstrated in clinical trials indicates that AOD-9604 is not a standalone dramatic weight loss solution
PROTECT FROM LIGHT
Contact support promptly after delivery, retain all packaging, and provide the order number and clear photographs requested for review